| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.36 | 0.05 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |